VASTX

VASTX Ltd is a UK-based space medicine and digital health company developing AI-enabled digital twin models to support safer medication use in human spaceflight and extreme environments. Its platform combines pharmacokinetics, physiology-based modelling, biometric data, biosampling and analogue mission evidence to predict how medicines may behave when human physiology is altered by microgravity, confinement, disrupted circadian rhythm and operational stress.

VASTX is positioned as one of the UK’s first dedicated commercial space pharmacology companies, addressing a critical gap in crew health and medical readiness for future commercial, lunar and long-duration missions. The company’s work is dual-use, with spaceflight applications translating back into terrestrial healthcare, including remote medicine, defence health, ICU, oncology and pharmaceutical R&D. VASTX aims to contribute specialist life-sciences and human-health expertise to the UK space sector, helping ensure that the UK plays a visible role in the future of space medicine, crew autonomy and healthcare beyond Earth.